General ZEPHYR project information

Last updated: 2023-04-11 11:39

Project name

Unidirectional endobronchial valve for the treatment of pulmonary emphysema

Project abbreviation


Project code


Primary organization that oversees implementation of project

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Partner organization participating in project

  • Not available

Organization that commissioned this project

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Organization providing monetary or material support

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Brief project description

In emphysema of the lung, small alveoli are systematically lost. In those places oxygen absorption is no longer possible, but this also causes the lungs to become stiff. This causes the inhaled air to become trapped in the diseased tissue, causing the affected lung tissue to expand. This expanded tissue compresses the healthy lung tissue, further reducing the surface area for oxygen uptake.
In this project medical data and material use are registrated in patients with pulmonary emphysema in whom one-way endobronchial valve is implanted. Registration by the implanting center is mandatory so that it retains its approval and can certify the service.

Regulatory framework of this project

Consult the regulatory framework information published on the pages.

This documentation is being updated regularly. We try to provide as correct, complete and clear as possible information on these pages. Nevertheless, if you see anything in the documentation that is not correct, does not match your experience or requires further clarification, please create a request (type : request for information) via our portal ( or send us an e-mail via to report this documentation issue. Please, do not forget to mention the URL or web address of the page with the documentation issue. We will then adjust the documentation as soon as possible. Thank you!